Lu Lu

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Shuai Xia, Meiqin Liu, Chao Wang et al. · Cell Research · 2020 · 1.4K citations · Full text

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

Xiaolong Tian, Cheng Li, Ailing Huang et al. · Emerging Microbes & Infections · 2020 · 1.3K citations · Full text

Viral Diagnostics, Viral Pathogenesis, Immunology +18

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

Shuai Xia, Yun Zhu, Meiqin Liu et al. · Cellular and Molecular Immunology · 2020 · 748 citations · Full text

Signal Transduction, Spike Protein, Signaling Pathway +7

Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications

Fan Wu, Aojie Wang, Mei Liu et al. · 2020 · 740 citations · Full text

Vaccination, Plasma Crp Levels, Viral Diagnostics +13

A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

Shuai Xia, Lei Yan, Wei Xu et al. · Science Advances · 2019 · 515 citations · Full text